A new drug in clinical trials is showing promise in lowering a key genetic risk factor for heart attacks and ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...

Two undergraduate medicine students have led a major study examining how cardioprotective glucose-lowering therapies -- medications that lower blood sugar and reduce the risk of heart disease in ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting ...

Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...

Axsome Therapeutics said on Tuesday it will narrow the focus of a late-stage study of its depression drug after an initial ...

Leap Therapeutics (LPTX) presented updated preliminary data from Part B of the DeFianCe study, a Phase 2, open-label, global study of ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Although it is impossible to become immune to Alzheimer's disease, there are a few lifestyle changes that could reduce your risk.

That sort of perverse effect pervades drug law enforcement, as illustrated by a new study that found drug seizures in San Francisco were associated with a substantial increase in overdose risk.

It stressed that establishing responsibility for the drug war “partly relies on evidence of centralized control over the violence.” The study also pointed out that the patterns of killings ...

There's newfound hope for stroke patients in recovery, with what researchers believe is the very first drug that can comprehensively ... therapeutic." The study was published in the journal ...